We are Allarta – a regenerative medicine company with platform technology for allogeneic cell therapies.
Beyond Encapsulation
Built on 30+ years of foundational expertise, Allarta’s proprietary platform is designed to overcome immune rejection, prevent cell escape and safely deliver cell and stem cell therapies.
Our lead product is a cell therapy focused on type 1 diabetes (T1D) as a first indication.
LATEST NEWS
Ontario life sciences startup, Allarta, receives award from JDRF to advance its work in creating a functional cure for type 1 diabetes
Founders
Allarta Life Science was co-founded in 2019 by Dr. Harald Stover, one of the world’s leading researchers in polymers and polymer hydrogels, and Maria Antonakos.
![headshot-harald-stover Harald Stover, PhD](https://allarta.com/wp-content/uploads/headshot-harald-stover.jpg)
Harald Stover, PhD
Founder and CEO
![headshot-maria-antonakos Harald Stover, PhD](https://allarta.com/wp-content/uploads/headshot-maria-antonakos.jpg)
Maria Antonakos, MBA
Founder and COO